Summary
Longevity supplements have gained traction in the post-COVID era, with the rise of nicotinamide mononucleotide (NMN) a classic example.
However, the scientific framework for evaluating the efficacy of these products is still in its early stages, said Dr. Raymond Chua, CEO of HSA.
He outlined chall…
Source: NutraIngredients.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
